In an infant with persistent eczema, recurrent wheeze, or chronic nasal symptoms, how should environmental allergy testing be performed, including age‑appropriate testing methods and interpretation criteria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Environmental Allergy Testing in Infants

Environmental allergy testing in infants with persistent eczema, recurrent wheeze, or chronic nasal symptoms should be performed using both skin prick testing (SPT) and serum-specific IgE (sIgE) testing, as either method alone will miss significant sensitizations in this age group.

Age-Appropriate Testing Methods

Dual Testing Approach Required

  • Both SPT and sIgE testing should be performed concurrently in infants and young children under 4 years of age, as discordance between these methods is substantial 1
  • In 80% of atopic children aged 18-48 months, one or more allergen sensitizations would be missed if only SPT were performed 1
  • In 38% of these children, sensitizations would be missed if only sIgE testing were performed 1
  • Agreement between SPT and sIgE is only fair for most allergens (κ = -0.04 to 0.50) in this age group 1

Technical Considerations for Infant Testing

  • SPT can be reliably performed from birth onward, though interpretation requires awareness of age-related hyporeactivity 2
  • Infants under 6 months show significant hyporeactivity to both histamine and allergen-induced wheals compared to older children 2
  • Positive SPT wheals in infants range from 2-5 mm diameter, smaller than in older children 2
  • Children with high total IgE (≥300 kU/L) are more likely to have positive sIgE results with negative corresponding SPT results 1

Clinical Context for Testing

When to Test

  • Children with persisting, recurrent, or severe symptoms suggestive of allergy should undergo diagnostic work-up regardless of age 3
  • Testing is particularly indicated in infants with eczema plus respiratory symptoms, as this combination increases risk 4

Allergen Selection by Age

  • In the first year of life, infants born to atopic families are sensitized to pollen aeroallergens more frequently than indoor allergens 5
  • Perennial allergic rhinitis (dust mite, animal dander) may present at very early ages 5
  • Seasonal allergic rhinitis typically does not develop until 2-7 years of age, as two seasons of exposure are generally required for sensitization 5
  • Food allergies in infancy primarily cause gastrointestinal symptoms and atopic dermatitis, rarely inducing nasal symptoms 5

Interpretation Criteria

Defining Atopic vs. Non-Atopic Disease

  • Positive SPT or sIgE to environmental allergens distinguishes atopic from non-atopic eczema, which has critical prognostic implications 4
  • Infants with atopic eczema (eczema plus sensitization) have 3.52 times greater risk of developing asthma compared to those with non-atopic eczema 4
  • Risk of allergic rhinitis is 2.91 times higher in children with atopic versus non-atopic eczema 4
  • Large SPT wheals indicative of food allergy further increase asthma risk (OR=4.61) 4

Integration with Clinical History

  • Neither SPT nor sIgE alone is sufficient; results must be combined with clinical history for accurate assessment 6
  • More than two-thirds of children with moderate-to-severe eczema have elevated total IgE (>1000 kU/L) 6
  • Specific IgE to grass and house dust mite are most frequent findings, though correlation with clinical history may be poor 6

Critical Pitfalls to Avoid

Common Testing Errors

  • Do not rely on a single testing modality in children under 4 years, as this will miss clinically significant sensitizations 1
  • Do not dismiss small wheal sizes in infants as negative; wheals of 2-5 mm can represent true sensitization 2
  • Do not assume negative SPT rules out sensitization if total IgE is very high; perform sIgE testing 1

Limitations of Evidence for Wheezing

  • For infants with persistent wheezing without eczema, evidence does not support routine food allergy testing to guide dietary changes 7
  • The American Thoracic Society recommends against empiric food avoidance in wheezing infants without eczema (conditional recommendation, very low quality evidence) 7
  • Research is needed to determine whether allergy testing-guided interventions improve clinical outcomes in this population 7

Practical Testing Algorithm

  1. Perform both SPT and sIgE testing to common environmental allergens (dust mite, grass pollen, animal danders) 1
  2. Include food allergens (especially egg) if eczema is present, as large reactions predict asthma risk 4
  3. Measure total IgE to help interpret discordant results 1, 6
  4. Interpret positive results as wheals ≥2 mm in infants, accounting for age-related hyporeactivity 2
  5. Correlate all test results with detailed clinical history before making management decisions 6

References

Research

Discordance between aeroallergen specific serum IgE and skin testing in children younger than 4 years.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2013

Research

Skin test reactivity in infancy.

The Journal of allergy and clinical immunology, 1985

Research

Skin prick test can identify eczematous infants at risk of asthma and allergic rhinitis.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2007

Guideline

the diagnosis and management of rhinitis: an updated practice parameter.

Journal of Allergy and Clinical Immunology, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.